See more : KWS SAAT SE & Co. KGaA (KWS.DE) Income Statement Analysis – Financial Results
Complete financial analysis of A-SPINE Asia Co., Ltd. (6758.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of A-SPINE Asia Co., Ltd., a leading company in the Healthcare industry within the Healthcare sector.
- GungHo Online Entertainment, Inc. (3765.T) Income Statement Analysis – Financial Results
- Exeo Entertainment, Inc. (EXEO) Income Statement Analysis – Financial Results
- Pacific Empire Minerals Corp. (PEMSF) Income Statement Analysis – Financial Results
- Nordson Corporation (NDSN) Income Statement Analysis – Financial Results
- YUTORI INC (5892.T) Income Statement Analysis – Financial Results
A-SPINE Asia Co., Ltd. (6758.TWO)
About A-SPINE Asia Co., Ltd.
A-SPINE Asia Co., Ltd., a medical device company, engages in the research, development, manufacture, and marketing of spinal implants and instruments in Taiwan, China, the Philippines, Australia, New Zealand, Iran, Vietnam, Indonesia, Spain, Trinidad, and Sri Lanka. The company offers spinal fixation systems, such as cervical anterior fixation, and thoracic and lumbar fixation systems; interbody fixation systems, including ACDF cages, PLIF and TLIF cages, and ALIF lumbar cages; balloon kyphoplasty products; and vertebral body replacement products. It also sells imported orthopedic medical devices. The company was founded in 2001 and is based in New Taipei City, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 391.26M | 330.16M | 309.67M | 369.97M | 0.00 |
| Cost of Revenue | 99.02M | 90.00M | 74.31M | 82.70M | 0.00 |
| Gross Profit | 292.24M | 240.16M | 235.36M | 287.28M | 0.00 |
| Gross Profit Ratio | 74.69% | 72.74% | 76.01% | 77.65% | 0.00% |
| Research & Development | 26.00M | 20.40M | 22.23M | 25.99M | 0.00 |
| General & Administrative | 33.37M | 32.32M | 29.49M | 35.13M | 0.00 |
| Selling & Marketing | 221.77M | 179.56M | 162.76M | 193.14M | 0.00 |
| SG&A | 255.14M | 211.87M | 192.25M | 228.27M | 0.00 |
| Other Expenses | 11.10M | 3.67M | 1.77M | 2.76M | 0.00 |
| Operating Expenses | 292.24M | 232.27M | 214.48M | 254.26M | 0.00 |
| Cost & Expenses | 381.86M | 322.27M | 288.79M | 336.95M | 0.00 |
| Interest Income | 482.00K | 306.00K | 46.00K | 139.00K | 668.00K |
| Interest Expense | 2.55M | 1.69M | 1.33M | 1.51M | 1.65M |
| Depreciation & Amortization | 15.57M | 16.16M | 15.72M | 13.05M | 0.00 |
| EBITDA | 29.78M | 27.86M | 38.43M | 48.92M | 81.41M |
| EBITDA Ratio | 7.61% | 8.49% | 12.41% | 13.24% | 0.00% |
| Operating Income | 9.40M | 11.86M | 22.70M | 35.92M | 0.00 |
| Operating Income Ratio | 2.40% | 3.59% | 7.33% | 9.71% | 0.00% |
| Total Other Income/Expenses | 2.26M | -1.85M | -1.32M | -1.57M | -1.33M |
| Income Before Tax | 11.66M | 10.01M | 21.38M | 34.35M | 0.00 |
| Income Before Tax Ratio | 2.98% | 3.03% | 6.90% | 9.29% | 0.00% |
| Income Tax Expense | 2.45M | 2.00M | 3.64M | 3.96M | 0.00 |
| Net Income | 9.21M | 8.01M | 17.74M | 30.39M | 0.00 |
| Net Income Ratio | 2.35% | 2.43% | 5.73% | 8.21% | 0.00% |
| EPS | 0.68 | 0.59 | 1.32 | 2.26 | 4.20 |
| EPS Diluted | 0.68 | 0.59 | 1.31 | 2.25 | 4.18 |
| Weighted Avg Shares Out | 13.47M | 13.47M | 13.47M | 13.47M | 13.47M |
| Weighted Avg Shares Out (Dil) | 13.51M | 13.52M | 13.54M | 13.54M | 13.54M |
Source: https://incomestatements.info
Category: Stock Reports